For the Inventor, By the Inventor

Enter assignee name

Boston, MA, United States of America

Praxis Precision Medicines, Inc.

USPTO Granted Patents = 35

EPO Patents = 9

Trademarks = 3

Forward Citations = 77

Loading Chart...

Loading Chart...

29 inventors (with patents filed for the assignee):

Gabriel Martinez Botella (26 out of 99 patents)

Andrew Mark Griffin (23 out of 37 patents)

Kiran Reddy (22 out of 25 patents)

4. Brian Edward Marron (21 out of 37 patents)

5. Marion Wittmann (4 out of 4 patents)

6. Margaret S Lee (3 out of 9 patents)

7. Nelson B Olivier (3 out of 3 patents)

8. Magnus Ronn (3 out of 11 patents)

9. Paul A Laskar (3 out of 4 patents)

10. Gabriel Maurice Belfort (3 out of 3 patents)

11. Sapna Makhija Garad (3 out of 3 patents)

12. Randall Wagner (3 out of 3 patents)

13. Carlos Loya (3 out of 3 patents)

14. Bernard Ravina (2 out of 7 patents)

15. Mahesh Padval (2 out of 2 patents)

Core Competencies:

Ion Channel Modulators

T-Type Calcium Channel Modulators

SCN2A-Related Disorders

KCNT1 Inhibitors

Positive Allosteric Modulators

Triazolo Compounds

Substituted Pyridines

GABA-A Modulators

Dynamic Clamps

Crystalline Forms

Compounds

Sodium Channel Activity

35 patents: Sort by Forward Citations

1. 12697331 - Methods of use of T-type calcium channel modulators (2026-08-04),

2. 12655151 - Ion channel modulators (2026-06-16),

3. 12618072 - METHODS OF TREATMENT OF SCN2A-RELATED DISORDERS (2026-05-05),

4. 12583849 - KCNT1 inhibitors and methods of use (2026-03-24),

5. 12582652 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyrazine as an ion channel modulator (2026-03-24),

6. 12552797 - Process for making (3-[cyclopropylethoxy(difluoro)methyl]-6-6[5-fluoro-6-(2,2,2-trifluoroethoxy-3-pyridyl]- [1,2,4]triazolo[4,3-a]pyrazine (2026-02-17),

7. 12528772 - Formulations of T-type calcium channel modulators and methods of use thereof (2026-01-20),

8. 12479844 - Ion channel modulators (2025-11-25),

9. 12404297 - Salts and crystal forms of GABA-positive allosteric modulator (2025-09-02),

10. 12344615 - Substituted pyridines as ion channel modulators (2025-07-01),

11. 12325711 - 3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-α]pyrazine as an ion channel modulator (2025-06-10),

12. 12259378 - Dynamic clamps and methods of use thereof (2025-03-25),

13. 12145939 - Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators (2024-11-19),

14. 12077502 - Formulations of T-type calcium channel modulators and methods of use thereof (2024-09-03),

15. 12030881 - Ion channel modulators (2024-07-09),

Company Overview

Praxis Precision Medicines, Inc. is a biotechnology company based in Boston, MA, focused on developing innovative therapies for patients with central nervous system disorders. The company specializes in precision medicine approaches, leveraging advanced research to create targeted treatments that address the underlying causes of neurological conditions. Praxis aims to transform the treatment landscape for patients suffering from various neurological and psychiatric disorders through its commitment to scientific excellence and patient-centric solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

35 Patents

#68 in Boston, MA

#583 in Massachusetts

#9,749 in US

#19,168 in the World

Boston, MA, United States of America

Praxis Precision Medicines, Inc.

Forward Citations = 77

29 inventors:

Gabriel Martinez Botella (26 out of 99 patents)

Andrew Mark Griffin (23 out of 37 patents)

Kiran Reddy (22 out of 25 patents)

4. Brian Edward Marron (21 out of 37 patents)

5. Marion Wittmann (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Praxis Precision Medicines, Inc.. Retrieved from https://idiyas.com/company/praxis-precision-medicines

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…